Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Larsson, P. Kippelen, S. Anderson, J. Brannan, B. Dahlén, S. E. Dahlén (Stockholm, Sweden; West London, United Kingdom; Camperdown, Australia). Sodium cromoglycate inhibits release of mast cell mediators and bronchoconstriction following hyperpnea in athletes. Eur Respir J 2010; 36: Suppl. 54, 4578

Member's Comments

No comment yet.

Related content which might interest you: Mast cell mediator release during refractoriness to mannitol-induced bronchoconstriction Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Inhibition of the airway response to mannitol with either eformoterol or sodium cromoglycate (SCG) does not alter leukotriene release in asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 443s Year: 2004 Inhalation of mannitol, used as a model for exercise-induced bronchoconstriction (EIB), causes release of leukotrienes and a mast cell marker in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001 Salbutamol attenuates nasal symptoms and mast cell degranulation by AMP challenge Source: Eur Respir J 2005; 26: Suppl. 49, 228s Year: 2005 Comparison of salbutamul, nedocromil sodium and disodium cromoglycate (DSCG) protective effects in patients with exercise induced bronchoconstriction (EIB) Source: Eur Respir J 2002; 20: Suppl. 38, 306s Year: 2002 Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review Source: Eur Respir J 2001; 17: 39-45 Year: 2001 Hyaluronan prevents exercise induced bronchoconstriction in asthmatic children Source: Annual Congress 2008 - New treatments for asthma Year: 2008 Extracellular and intracellular magnesium before and after methacholine-induced bronchoconstriction in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 504s Year: 2002 AMP nasal provocation elicits mast cell degranulation: inhibition by topical heparin Source: Eur Respir J 2004; 24: Suppl. 48, 590s Year: 2004 Formoterol protects against platelet-activating factor-induced effects in asthma Source: Eur Respir J 2004; 23: 71-75 Year: 2004 Budesonide and formoterol inhibit bronchial epithelial cell-mediated eosinophil superoxide production Source: Eur Respir J 2005; 26: Suppl. 49, 123s Year: 2005 Mast cell generated cyclooxygenase products protect from airway hyperresponsiveness in a model of chronic asthma Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 LSC 2011 Abstract: Combined nasal exposure to sodium hypochlorite and ovalbumin induces airway hyperreactivity in mice through activation of the TRPA1 channel and mast cells Source: Annual Congress 2011 - Environmental exposure and disease mechanisms Year: 2011 Effect of pinacidil, a KATPCO, on airway hyperresponsiveness and remodeling in guinea-pigs with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 80s Year: 2004 Sodium sulfite enhances rhinovirus-induced chemokine production in airway epithelial cells Source: Annual Congress 2012 - Airway infections in children: from risk factors to treatment Year: 2012 Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma Source: Eur Respir J 2002; 19: 872-878 Year: 2002 Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Source: Eur Respir J 2006; 27: 944-950 Year: 2006 Effect of long-term treatment with inhaled furosemide and nedocromil sodium on exercise-induced broncho-obstruction in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 495s Year: 2001